This research is significant as Humira is the only approved treatment for Pyoderma Gangrenosum in Japan. The study tested Humira (Adalimumab), an injectable medication, on approximately 60 ...

US Food and Drug Administration awards Fast Track designation for the treatment of ulcerative pyoderma gangrenosumFast track follows recently reported orphan drug designation by both US FDA and ...

Orphan Drug Designation granted for treatment of pyoderma gangrenosum (PG) from US FDA and EMAProductive end-of-phase II meeting with FDA held for PG; dialogue ongoing related to Phase III program ...